CURE Pharmaceutical To Present at Benzinga Cannabis Capital Conference
January 09, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Jan. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will host an investor presentation at the...
CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
November 14, 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s...
CURE Pharmaceutical to Present at CannX 2018 International Medical Cannabis Conference
October 10, 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's CannX Conference on October...
CURE Pharmaceutical to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
September 28, 2018 07:25 ET
|
CURE Pharmaceutical
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's MicroCap Conference on October...
CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules
September 25, 2018 08:45 ET
|
CURE Pharmaceutical
LOS ANGELES, Sept. 25, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, announced the allowance of an oral thin film patent (U.S. Patent...
Pascal Biosciences: Cannabinoids Could Play a Role in Destroying Cancer Cells -- CFN Media
July 03, 2018 09:00 ET
|
CFN Media
SEATTLE, July 03, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced...
CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference
June 05, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the...
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
April 04, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE...
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
April 03, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened...
Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing
March 14, 2018 09:00 ET
|
CURE Pharmaceutical
LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical, (OTC:CURR), an innovative drug delivery and development company, today named Steven Ruhl Vice President of Manufacturing....